Parallel Fluidics Secures $7M to Revolutionize Microfluidic Manufacturing
Slice of Healthcare Team
Nov 08, 2024
Key Highlights
- $7M seed funding round led by J2 Ventures with 8VC and Praxis participation
- Funding to enhance on-demand design and manufacturing for microfluidics
- Launch of MV-2 microvalve, optimized for point-of-care applications
- Accelerates diagnostics, drug discovery, and precision medicine
Source: PR Newswire
Notable Quotes
“ Scientists and engineers developing the next breakthrough life science technology shouldn't be forced to reinvent the wheel when it comes to microfluidic systems, especially in applications like point-of-care diagnostics. ”
Jon Bronson, PhD, Managing Partner at J2 Ventures
“ At Parallel Fluidics, we are on a mission to help scientific teams build scalable and reliable products to identify diseases faster and develop more effective medicines. ”
Josh Gomes, CEO at Parallel Fluidics
“ Solutions like Parallel Fluidics' microfluidic systems are filling that gap with their microvalves and enabling faster, more reliable processes that can help us enhance patient outcomes. ”
Lionel Matthys, Chief Product Officer at Overture Life
